Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
Indian J Chest Dis Allied Sci
;
1989 Jan-Mar; 31(1): 21-4
Article
Dans Anglais
| IMSEAR
| ID: sea-29798
ABSTRACT
Combination chemotherapy with 3 drugs (vincristine + cyclo-phosphamide + methotrexate of adriamycin) were administered to 36 cases of advanced bronchogenic carcinoma. The median survival for patients with small cell carcinoma (SCC) was 24.5 weeks whereas that for non small cell carcinoma was 27.5 weeks (P greater than 0.05). Fifty-five per cent of the patients survived beyond 6 months; 30.5 per cent survived beyond 1 year and 11 per cent of the patients survived beyond two years. Adriamycin did not prove more effective than methotrexate. However, omission of adriamycin from the regimen may reduce the cost of chemotherapy.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Facteurs temps
/
Vincristine
/
Sujet âgé
/
Femelle
/
Humains
/
Mâle
/
Carcinome bronchogénique
/
Protocoles de polychimiothérapie antinéoplasique
/
Méthotrexate
/
Analyse coût-bénéfice
langue:
Anglais
Texte intégral:
Indian J Chest Dis Allied Sci
Année:
1989
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS